ES8801241A1 - Un procedimiento para preparar laudanos - Google Patents

Un procedimiento para preparar laudanos

Info

Publication number
ES8801241A1
ES8801241A1 ES557153A ES557153A ES8801241A1 ES 8801241 A1 ES8801241 A1 ES 8801241A1 ES 557153 A ES557153 A ES 557153A ES 557153 A ES557153 A ES 557153A ES 8801241 A1 ES8801241 A1 ES 8801241A1
Authority
ES
Spain
Prior art keywords
medicaments
preparation
labdan
derivatives
labdanes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES557153A
Other languages
English (en)
Other versions
ES557153A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Hoechst Roussel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharmaceuticals Inc filed Critical Hoechst Roussel Pharmaceuticals Inc
Publication of ES8801241A1 publication Critical patent/ES8801241A1/es
Publication of ES557153A0 publication Critical patent/ES557153A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65502—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a three-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Fire-Extinguishing Compositions (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
  • Lubricants (AREA)
  • Ink Jet (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
  • Pyrane Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE LAUDANOS DE FORMULA GENERAL (I), Y SUS SALES DE ADICION DE ACIDO FARMACEUTICAMENTE ACEPTABLES. COMPRENDE LAS OPERACIONES DE TRATAR UN COMPUESTO DE FORMULA GENERAL (II), EN LA QUE R3, R4 Y R5 SON, CADA UNO INDEPENDIENTEMENTE, ALQUILO INFERIOR, CON UN COMPUESTO DE F''ORMULA: HAL-Z-HAL, EN LA QUE HAL ES BROMO O CLORO; Y Z ES SO O CO, EN PRESENCIA DE UNA BASE ORGANICA; Y DE ELIMINAR DEL COMPUESTO OBTENIDO EL GRUPO SILILO MEDIANTE TRATAMIENTO CON FLUORURO DE HIDROGENO ACUOSO, EN ACETONITRILO, A TEMPERATURA AMBIENTE, PARA OBTENER EL COMPUESTO BUSCADO DE FORMULA GENERAL (III). DE APLICACION EN EL TRATAMIENTO DE UNA PRESION INTRAOCULAR ELEVADA.
ES557153A 1985-03-01 1986-10-30 Un procedimiento para preparar laudanos Expired ES8801241A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70728385A 1985-03-01 1985-03-01

Publications (2)

Publication Number Publication Date
ES8801241A1 true ES8801241A1 (es) 1988-01-01
ES557153A0 ES557153A0 (es) 1988-01-01

Family

ID=24841093

Family Applications (4)

Application Number Title Priority Date Filing Date
ES552465A Expired ES8705414A1 (es) 1985-03-01 1986-02-27 Un procedimiento para preparar laudanos
ES557153A Expired ES8801241A1 (es) 1985-03-01 1986-10-30 Un procedimiento para preparar laudanos
ES557152A Expired ES8801240A1 (es) 1985-03-01 1986-10-30 Un procedimiento para preparar laudanos
ES557151A Expired ES8707724A1 (es) 1985-03-01 1986-10-30 Un procedimiento para preparar laudanos

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES552465A Expired ES8705414A1 (es) 1985-03-01 1986-02-27 Un procedimiento para preparar laudanos

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES557152A Expired ES8801240A1 (es) 1985-03-01 1986-10-30 Un procedimiento para preparar laudanos
ES557151A Expired ES8707724A1 (es) 1985-03-01 1986-10-30 Un procedimiento para preparar laudanos

Country Status (15)

Country Link
EP (1) EP0193132B1 (es)
JP (1) JPS61210081A (es)
KR (1) KR910007967B1 (es)
AT (1) ATE62683T1 (es)
AU (1) AU577928B2 (es)
DE (1) DE3678736D1 (es)
DK (1) DK92786A (es)
ES (4) ES8705414A1 (es)
FI (1) FI860842A (es)
GR (1) GR860571B (es)
HU (1) HUT42080A (es)
NO (1) NO860758L (es)
PH (1) PH23778A (es)
PT (1) PT82097B (es)
ZA (1) ZA861505B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE60767T1 (de) * 1984-12-14 1991-02-15 Hoechst Roussel Pharma Aminoacyllabdane, verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung als arzneimittel.
IN163242B (es) * 1985-05-03 1988-08-27 Hoechst India
JPS6310783A (ja) * 1985-11-15 1988-01-18 Nippon Kayaku Co Ltd 新規フオルスコリン誘導体
AU591196B2 (en) * 1985-11-15 1989-11-30 Nippon Kayaku Kabushiki Kaisha Novel forskolin derivatives
US5247097A (en) * 1986-08-28 1993-09-21 Hoechst-Roussel Pharmaceuticals Incorporated Oxolabdanes
US4740522A (en) * 1986-08-28 1988-04-26 Hoechst-Roussel Pharmaceuticals Inc. Oxolabdanes useful as pharmaceuticals for reducing intraocular pressure
US5646175A (en) * 1987-12-28 1997-07-08 Hoechst Marion Roussel, Inc. Carbamoyloxylabdane compounds
US4920146A (en) * 1986-12-29 1990-04-24 Hoechst Roussel Pharmaceuticals Inc. Carbamoyloxylabdane compounds useful in reducing intraocular pressure
CA1307530C (en) * 1986-12-29 1992-09-15 Hoechst-Roussel Pharmaceuticals Inc. Carbamoyloxylabdanes, intermediates and a process for the preparation thereof and their use as medicaments
US5302730A (en) * 1987-06-29 1994-04-12 Nippon Kayaku Kk Process for the preparation of 6,7-diacyl-7-deacetylforskolin derivatives
JP2504934B2 (ja) * 1987-06-29 1996-06-05 日本化薬株式会社 １，６，７−トリアシルフオルスコリン誘導体
JPH0684367B2 (ja) * 1987-06-29 1994-10-26 日本化薬株式会社 フオルスコリン誘導体の新規製造法
US4902696A (en) * 1987-10-08 1990-02-20 Hoechst-Roussel Pharmaceuticals, Inc. Synergistic intraocular pressure lowering combinations
US5846992A (en) * 1987-10-08 1998-12-08 Hoechst Marion Roussel, Inc. Synergistic intraocular pressure lowering combinations
DE3737353A1 (de) * 1987-11-04 1989-05-18 Hoechst Ag Neue acyllabdan-derivate, ein verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
IN168181B (es) * 1987-12-01 1991-02-16 Hoechst India
US4883793A (en) * 1988-05-09 1989-11-28 Hoechst-Roussel Pharmaceuticals Inc. Hydrazinocarbonyloxylabdanes for treating cardiac failure
US5051132A (en) * 1989-06-15 1991-09-24 Nippon Kayaku Kabushiki Kaisha Lyophilized preparation of 6-(3-dimethylaminopropionyl)forskolin
US5093336A (en) * 1989-07-06 1992-03-03 Hoechat-Roussel Pharmaceuticals, Inc. 6- and 7-deoxyforskolin and derivatives thereof
EP0447962A1 (en) * 1990-03-17 1991-09-25 Hoechst Aktiengesellschaft Labdanes and process for their preparation
IE911192A1 (en) * 1990-04-12 1991-10-23 Merck & Co Inc Substituted aromatic sulfonamides as antiglaucoma agents
JP3031498B2 (ja) * 1990-04-12 2000-04-10 メルク エンド カムパニー インコーポレーテッド 抗緑内障剤としての置換芳香族スルホンアミド類
US5250682A (en) * 1990-07-24 1993-10-05 Hoechst Aktiengesellschaft Process for the preparation of 6-[3-substitutedaminopropionyl]-7-deacetylforskolin derivatives
KR102048856B1 (ko) * 2019-09-20 2019-11-26 주식회사 램프쿡 보조뚜껑을 구비하는 조리용기용 뚜껑

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4517200A (en) * 1982-12-27 1985-05-14 Schering-Plough Corporation Method for treating allergic reactions with forskolin
ATE60767T1 (de) * 1984-12-14 1991-02-15 Hoechst Roussel Pharma Aminoacyllabdane, verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung als arzneimittel.
IN163242B (es) * 1985-05-03 1988-08-27 Hoechst India

Also Published As

Publication number Publication date
PT82097B (pt) 1988-07-01
DK92786D0 (da) 1986-02-28
ZA861505B (en) 1987-06-24
AU5423686A (en) 1986-09-04
HUT42080A (en) 1987-06-29
EP0193132B1 (en) 1991-04-17
DK92786A (da) 1986-09-02
FI860842A0 (fi) 1986-02-27
DE3678736D1 (de) 1991-05-23
ES552465A0 (es) 1987-05-01
EP0193132A2 (en) 1986-09-03
ES557151A0 (es) 1987-08-16
FI860842A (fi) 1986-09-02
ATE62683T1 (de) 1991-05-15
ES557153A0 (es) 1988-01-01
KR910007967B1 (ko) 1991-10-04
KR860007277A (ko) 1986-10-10
GR860571B (en) 1986-06-18
ES557152A0 (es) 1988-01-01
EP0193132A3 (en) 1987-07-29
NO860758L (es) 1986-09-02
PT82097A (en) 1986-03-01
JPS61210081A (ja) 1986-09-18
ES8705414A1 (es) 1987-05-01
PH23778A (en) 1989-11-03
ES8707724A1 (es) 1987-08-16
AU577928B2 (en) 1988-10-06
ES8801240A1 (es) 1988-01-01

Similar Documents

Publication Publication Date Title
ES8705414A1 (es) Un procedimiento para preparar laudanos
HUT37410A (en) Process for the production of benzothiazole- and benzothiophene-derivatives, as well as of therapeutic preparations containing them as agent
DE3571982D1 (en) Benzisoselenazolethiones,process for their preparation and pharmaceutical products containing these compounds
ES8801243A1 (es) Procedimiento para la obtencion de medicamentos que contienen 1-heteroaril-4--aril-pirazolin-5-onas.
DE3172006D1 (en) Novel quinazoline-dione compounds, process for production thereof and pharmaceutical use thereof
EP0302423A3 (en) 1-phenyl-3-(1-piperazinyl)-1h-indazoles, a process and intermediates for their preparation, and the use thereof as medicaments
AR243877A1 (es) Procedimiento para la preparacion de derivados de 8,13-epoxi-9alfa-hidroxi-1alfa lad-14-en-11-ona e intermediarios para uso en dicho procedimiento.
ES2023560A6 (es) Procedimiento para la produccion de hidrato de cefradina y solvato de cefradina y dimetilformamida.
AU8306987A (en) Novel carbamoyloxylabdanes, intermediates and a process for the preparation thereof and their use as medicaments
EP0268256A3 (en) 12-halogenated forskolin derivatives, intermediates and a process for the preparation thereof and their use as medicaments
EP0257631A3 (en) Oxolabdanes, a process for their preparation and their use as medicaments
ES8105711A1 (es) Un metodo de preparar derivados de piperidina
ZA855584B (en) New combination product,a process for its preparation and its use as a medicament
ES8705457A1 (es) Procedimiento para producir nuevos derivados de antibioticosdel grupo de la pluramicina
ES8609301A1 (es) Procedimiento para la obtencion de 3-metil-7-fluor-5-nitro- benzotiofeno
EP0200132A3 (en) (aminoalkylthio)hydroxydibenzoxepins, a process for their preparation and their use as medicaments
ES8606375A1 (es) Un procedimiento para preparar un derivado de aminoprpilaminobleomicina
ES8608504A1 (es) Un procedimiento para preparar (6,11-dihidro-11-oxodibenznb,e)oxepinil)pentanoles

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19960603